Reddy’s and Mylan beat Vimovo

Two US method-of-treatment patents protecting Horizon Pharma’s Vimovo (naproxen/esomeprazole) delayed-release tablets up to 2031 are invalid on the ground of indefiniteness, Dr Reddy’s and Mylan have convinced New Jersey District Judge Stanley Chesler.